Articles

Page 18 of 20

Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus

Authors: Y Zhang, D Patel and S Fan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P47

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia

Authors: P Velasco, L Dutcher, DA Davis and R Yarchoan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P45

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

Authors: P Unemori, P Hunt, K Leslie, E Sinclair, S Deeks, J Martin and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P43

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

Authors: TS Uldrick, A Mosam, F Shaik, G Friedland, D Skadden, JP Jordaan, J Aboobaker and HM Coovadia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P41

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice

Authors: S-H Sin, FD Fakhari and DP Dittmer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P39

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia

Authors: F Samaniego, Z Berkova, H Maeng, S Wang and J Wise

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P37

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus

Authors: S Sakakibara and G Tosato

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P35

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
HIV-associated bladder cancer: diagnosis and management

Authors: L Pantanowitz, EM Gaughan, BJ Dezube, M Bower and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P34

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion

Authors: L Pantanowitz, K Früh, D Aboulafia, S Marconi and BJ Dezube

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P33

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Colon adenocarcinoma in HIV infected patients

Authors: C Chapman, D Aboulafia, BJ Dezube and L Pantanowitz

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P32

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium

Authors: P Nowicki, A Hoover, K De Geest, M Goodheart, M Lace, T Haugen, L Turek, G Strand, A Bossler, A Klingelhutz and J Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P31

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon

Authors: P Ndom, ZK Bissek, C Takouchop, MT Obama, G Bengono and RW Ryder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma

Authors: S Montaner, R Chaisuparat, J Hu and BC Jham

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P29

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Genetic resistance to GAHV-2 induced lymphoma in the chicken model

Authors: MM Miller, Y Wang, RM Goto, PS Wakenell and RI Taylor Jr

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma

Authors: MS McGrath, M Salemi, R Grey, D Galligan and SL Lamers

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P27

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival

Authors: E Forte and MA Luftig

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era

Authors: D Serraino, S Bruzzone, B Suligoi, A De Paoli, J Polesel, B Longo, S Boros, P Piselli, L Dal Maso, L Camoni and G Rezza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O25

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration

Authors: A Jaquet, DK Ekouevi, J Bashi, M Aboubakrine, E Messou, M Maiga, D Zannou, C Guei, O Ba-Gomis, A Minga, G Allou, J Sasco and F Dabis

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma

Authors: DP Widney, D Gui, JW Said, EC Breen, R Detels and O Martinez-Maza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Profiling viral and host microRNA expression in cells infected with KSHV and EBV

Authors: D Whitby, W Miley, R Bagni, V Marshall, S-J HanJ, J Hu, RL Skalsky, CH Kim, F Ruscetti, R Little, R Yarchoan and R Renne

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O23

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations

Authors: E Queiroga, G Gualco, L Weiss, D Dittmer, I Araujo, C Klumb, W Harrington Jr, E Os and C Bacchi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Implementation of a "see and treat" cervical cancer prevention program linked to HIV care in Zambia

Authors: KS Pfaendler, MH Mwanahamuntu, VV Sahasrabuddhe, JSA Stringer, MI Hicks and GP Parham

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O21

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)

Authors: R Yarchoan, D O'Mahony, K Aleman, KM Wyvill, D Whitby, W Bernstein, S Pittaluga, ES Jaffe, G Tosato, DA Davis, SM Steinberg and RF Little

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O20

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas

Authors: M Guadalupe, Y Flahive, S Westbrook, S Redding, D Bullock, V Sankar, B Agan, S Barbieri, CK Yeh, H Dang and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma

Authors: DP Dittmer, AJ O'Hara, L Wang, BJ Dezube, W Harrington Jr and B Damania

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O19

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

Authors: LW Qian, W Greene, FC Ye and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation

Authors: JN Martin, M Laker, A Kambugu, D Janka, J Orem, A Mwaka, T Maurer and EK Mbidde

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer

Authors: PW Nowicki, WC Spanos, DW Lee, ME Anderson, AJ Hoover and JH Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo

Authors: AL Dufresne, D Fu and RF Ambinder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

Authors: E Lanoy, JP Spano, F Bonnet, F Boué, C Katlama and D Costagliola

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)

Authors: A Krishnan, J Zaia, J Alvarnas, N Kogut, J Cai, A Nademanee, J Palmer, N Tsai and SJ Forman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034

Authors: A Chadburn, A Chiu, Y Lee, X Chen, E Hyjek, A Banhmam, A Noy, A Kaplan, J Sparano, K Bhatia and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma

Authors: P Lu, C Yang, I Guasparri, W Harrington, YL Wang and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses

Authors: P Gasperini and G Tosato

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease

Authors: D Camarillo, K Leslie, P Unemori, A Koba Yashi, K McCune-Smith and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States

Authors: E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni and EA Engels

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Dendritic cell-mediated infection of primary B cells with KSHV

Authors: R Bagni, E Barsov, B Ortiz-Conde, D Dittmer, V Kewalramani, D Ott, C Sadowski, P Tuma, F Ruscetti and D Whitby

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

Authors: K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik and WH Wilson

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)

Authors: LW Ayers, G Dominguez and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

Authors: A Bhatt, P Bhende and B Damania

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O7

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting

Authors: LW Ayers, M Ogwang, W Zhou, SM Mbulaiteye and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

Authors: GM Clifford, M Rickenbach and S Franceschi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

Authors: HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem and C Casper

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis

Authors: DJ Alcendor, WQ Zhu, P Desai and GS Hayward

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Authors: M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene and F Bonnet

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria

Authors: P Agaba, E Anya, Z Hassan, L Apena, O Agbaji, M Mua'Zu, B Badung and J Idoko

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers

Authors: R Modali, J Goedert, E Engels, LW Ayers and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL

Authors: D Mani and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF

Articles

Affiliated with

Follow

Annual Journal Metrics

Infectious Agents and Cancer

Contact us